EP3436054

ALLERGAN
Application Number
EP17784058A
Filing Date
Sep 13, 2017
Status
Patent Maintained As Amended
Jun 24, 2022
Grant Date
Jul 27, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Biblio Summary

The patent EP3436054B2 was granted on Jul 27, 2022 by Allergan The patent is currently Patent Maintained As Amended.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

IPSEN PHARMAMay 12, 2020ADMISSIBLE

Patent citations in opposition refer to prior patents or publications that may challenge the validity of a contested patent. These references help assess whether the invention is truly novel or overlaps with existing intellectual property.

Citation PhasePatent NumberPatent LinkCited Text
OppositionEP2692350B2
N/A
OppositionWO0158472
N/A
OppositionWO2009008595
N/A
OppositionEP2679217
N/A
OppositionAU2009339292B
N/A

Access Full Citation Information

Get a free, in-depth citation report including examiner, opposition, and international search citations.

Get Free Citation Report

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.